Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib is an anti-cancer medication for the treatment of acute…
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
Trelagliptin is an orally active dipeptidyl peptidase (DPP)-4 inhibitor approved in Japan for the treatment of…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
BRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to…
Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used…
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and…
Avzivi® (Bevacizumab-tnjn) sold under the brand name POBEVCY (普贝希) in China, is a humanized monoclonal antibody…
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with specific mutations…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
The targeted drug selpercatinib has been a treatment option for some people with lung cancer or…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Pemigatinib is a type of targeted cancer drug. It is a treatment for bile duct cancer that…
Cabozantinib is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular…
Copyright © 2021-2022 LienTeh.net All rights reserved.
